Inventor
Joseph Armand Picard
Inventor
Canton, MI, US
Overview
Patents· 51 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Dprimary
C07DHeterocyclic compounds37%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations28%
C07CAcyclic or carbocyclic compounds25%
A61KPreparations for medical, dental or toiletry purposes5%
E21BEarth or rock drilling2%
H04MTelephonic communication2%
Y10TTechnical subjects covered by former us classification1%
PatentTitleYear
7,132,424'Monocyclic derivatives as matrix metalloproteinase inhibitors'20066,977,261'Azaisoquinoline derivatives as matrix metalloproteinase inhibitors'20056,962,922'Alkynylated quinazoline compounds'20056,943,174'6,5-Fused bicyclic heterocycles'20056,906,094'1,2,4-tribsubstituted benzenes as inhibitors of 15-lipoxygenase'20056,906,092'Method of inhibiting matrix metalloproteinases'20056,849,648'Phenylene alkyne matrix metalloproteinase inhibitors'20056,828,326'Pyrimidinone fused bicyclic metalloproteinase inhibitors'20046,677,355'Hydroxamic acid compounds useful as matrix metalloproteinase inhibitors'20046,656,932'Benzo thiadiazine matrix metalloproteinase inhibitors'20036,624,177'Matrix metalloproteinase inhibitors and their therapeutic uses'20036,620,835'Method of inhibiting matrix metalloproteinases'20036,559,142'Sulfonamide matrix metalloproteinase inhibitors'20036,492,422'Tricyclic sulfonamides and their derivatives as inhibitors of matrix metalloproteinases'20026,420,408'Tricyclic sulfonamides and their derivatives as inhibitors of matrix metalloproteinases'20026,350,885'Tricyclic heteroaromatics and their derivatives as inhibitors of matrix metalloproteinases'20026,294,674'Dibenzofuran sulfonamide matrix metalloproteinase inhibitors'20016,117,869'Compounds for and methods of inhibiting matrix metalloproteinases'20006,093,744'N-acyl sulfamic acid esters useful as hypocholesterolemic agents'20006,020,366'Butyric acid matrix metalloproteinase inhibitors'20005,981,595'Sulfonyl urea and carbamate ACAT inhibitors'19995,958,972'Tricyclic inhibitors of matrix metalloproteinases'19995,693,657'Heterocyclic-substituted alkyl amide acat inhibitors'19975,665,764'Tricyclic inhibitors of matrix metalloproteinases'19975,646,170'Tetrazole alkyl amide acat inhibitors'19975,633,287'N-acyl sulfamic acid esters (or thioesters), N-acyl sulfonamides, and n-sulfonyl carbamic acid esters (or thioesters) as hypercholesterolemic agents'19975,510,379'Sulfonate ACAT inhibitors'19965,502,198'.alpha.-aryl or heteroaryl-substituted amide ester ACAT inhibitors'19965,491,172'N-acyl sulfamic acid esters (or thioesters), N-acyl sulfonamides, and N-sulfonyl carbamic acid esters (or thioesters) as hypercholesterolemic agents'19965,491,170'.beta.-carboxy sulfonamide ACAT inhibitors'19965,489,611'Method for lowering plasma levels of lipoprotein (a)'19965,441,975'Pyrazolo-substituted alkyl amide acat inhibitors'19955,420,339'Alpha-aryl or heteroaryl-substituted amide ester ACAT inhibitors'19955,384,328'Oxysulfonyl carbamates'19955,366,987'Isoxazolyl-substituted alkyl amide ACAT inhibitors'19945,364,882'Oxysulfonyl urea ACAT inhibitors'19945,336,690'Aminosulfonyl carbamates composition and method of use to treat hypercholesterolemia and atherosclerosis'19945,288,757'Aminosulfonyl urea ACAT inhibitors and a method of lowering blood cholesterol levels therewith'19945,254,715'Aminosulfonyl carbamates'19935,254,589'Sulfonyl urea and carbamate ACAT inhibitors'19935,245,068'Oxysulfonyl carbamates'19935,214,206'Aminosulfonyl urea ACAT inhibitors'19935,198,466'Oxysulfonyl urea ACAT inhibitors'19935,189,058'Iminodicarbonic, iminodicarbonodithioic, and thiocarbonylcarbamic acid esters useful as ACAT inhibitors'19935,153,223'Biurets, aminocarbonyl carbamates, and aminocarbonyl thiocarbamates useful as ACAT inhibitors'19925,102,893'Trans-6-(2-(n-heteroaryl-3,5-disubstituted)pyrazol-4-yl)-ethyl- or ethenyl)tetrahydro-4-hydroxypyran-2-one inhibitors of cholesterol biosynthesis'19924,957,971'Trans-6-(2-(N-heteroaryl-3,5-disubstituted)pyrazol-4-yl)-ethyl)-or ethenyl)tetrahydro-4-hydroxypyran-2-one inhibitors of cholesterol biosynthesis'19904,923,861'6-(2-(2-(Substituted amino)-3-quinolinyl) ethenyl and ethyl) tetrahydro-4-hydroxypyran-2-one inhibitors of cholesterol biosynthesis'19904,761,419'6-(((substituted)quinolinyl)ethyl)-and ethenyl)tetrahydro-4-hydroxypyran-2-one inhibitors of cholesterol biosynthesis'19884,437,524'Well drilling apparatus'19844,423,645'Pipe spinner'1984Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1984Patents assigned to VARCO INT (2)· patent assignee history
1984Based in Fountain Valley, CA, US· patent location history
1988–2006Patents assigned to WARNER LAMBERT CO (49)· patent assignee history
1988–1990Based in Ann Arbor, MI, US· patent location history
1992–1999Based in Ypsilanti, MI, US· patent location history
1996–2006Based in Canton, MI, US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| WARNER LAMBERT CO | 49 | 1988–2006 |
| VARCO INT | 2 | 1984 |
Locations
| Location | Patents | Span |
|---|---|---|
| Canton, MI, US | 25 | 1996–2006 |
| Ypsilanti, MI, US | 21 | 1992–1999 |
| Ann Arbor, MI, US | 3 | 1988–1990 |
| Fountain Valley, California, US | 2 | 1984 |